Lyell Immunopharma, Inc.
SEC Filing List
LYEL CIK: 0001806952
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/11/2026 | |||
| SCHEDULE 13G/A | 05/08/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Lyell Immunopharma, Inc. | Workiva Inc. Wdesk FA01 /fa | 05/06/2026 | |
| 8-K | Current report filing | Lyell Immunopharma, Inc. | Workiva Inc. Wdesk FA01 /fa | 05/06/2026 | |
| ARS | Annual report to security holders | Lyell Immunopharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Lyell Immunopharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| DEF 14A | Definitive proxy statements | Lyell Immunopharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |||
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 04/14/2026 | ||
| CORRESP | A correspondence can be sent as a docume... | Lyell Immunopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/13/2026 | |
| No record found. | |||||
| Load More | |||||
